Abstract
Background The ICU environment is disruptive to a patient’s biological rhythms where sleep-wake cycles are often desynchronized from the environmental day-night changes. This puts patients at increased risk to develop delirium with consequent fiscal pressure for the health care system. An underappreciated dimension is how time-specific patient phenotypes in the critical care environment relate to clinical outcomes. We set out to analyze how rhythmic components (or the lack thereof) in physiological data streams sampled at high resolution in the ICU were associated with the future incidence of delirium and death. To offer cues for further interrogation into mechanism and risk prognosis, we examined differences in 24-hour fluctuations of clinical labs in ICU patient populations at risk.
Methods Rhythmic components using dipping ratios and JTK_CYCLE statistics were derived from 24-hour blood pressure and heart rate measurements available from ICU patient admissions recorded in the MIMIC IV database. Logistic adjusted regression models assessed the association between disrupted vital sign rhythms and the future incidence of delirium during the same hospital admission and death. Aggregation of numeric clinical lab measurements across the first 24 hours from all patient admissions allowed modelling of rhythmic patterns and subsequent association studies to link potential biochemical mechanisms to perturbed vital sign rhythms and adverse ICU outcomes.
Results Patients with reverse blood pressure dipping were at a 40% higher risk to have a diagnosis of delirium (Odds Ratio: 1.40, 95% CI: 1.14-1.72) and a 13% increased risk of death (Odds Ratio: 1.13, 95% CI: 1.02-1.26). Compared to the patient population with nocturnal blood pressure dip, reverse dippers showed 24-hour biochemistry profiles suggestive of altered circadian programs specifically in clinical parameters of renal, metabolic, and hemostatic function.
Conclusions Reverse blood pressure dipping can be an early sign for the future development of delirium in the ICU and is accompanied by disrupted biorhythms across multiple organ systems. Dampened and reversed heart rate and blood pressure rhythms are associated with a higher risk for death in ICU patients. Considering the inclusion of these risk factors in preventive care may improve patient outcomes and reduce burden on the health care system.
Competing Interest Statement
CS is the Robert L. McNeil Jr. Fellow in Translational Medicine and Therapeutics. GAF is the McNeil Professor of Translational Medicine and Therapeutics. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The MIMIC IV study was approved by the institutional review board at the Beth Israel Deaconess Medical Center and was granted a waiver of informed consent.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.